Document is current
Any future updates will be listed below
-
Authors
Naymagon, Leonard https://orcid.org/0000-0002-6312-1307
Roehrs, Philip
Hermiston, Michelle
Connelly, James
Bednarski, Jeffrey
Boelens, Jaap-Jan
Chandrakasan, Shanmuganathan
Dávila Saldaña, Blachy
Henry, Michael M.
Satwani, Prakash
Ray, Anish
Walkovich, Kelly
Teachey, David
Behrens, Edward M.
Canna, Scott W.
Kumar, Ashish
- License Information
-
More Information
Article History
Received: 24 May 2024
Accepted: 24 March 2025
First Online: 26 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: LN has no conflicts to disclose. PR has served on advisory board for SOBI. MH has served on advisory board for SOBI. JC has served on advisory board for SOBI. JB is advisor to Horizon Therapeutics, SOBI, and Prime Medicine. JJB is a consultant for Bluebird Bio, Avrobio, Bluerock, Omeros, Equillium, Sanofi, Medexus, and SOBI. SC has served on advisory board for SOBI. BDS has served on advisory board for SOBI. MMH has served on advisory board for SOBI. PS is a consultant for SOBI, Takeda, Mesoblast, and Atara Biotherapeutics. AR has served on an advisory board for SOBI. KW is on the advisory board for Pharming, Horizon Pharma, and AstraZeneca, on the steering committee for SOBI, and local PI for a clinical trial conducted by X4 Pharma. DT serves on advisory boards for SOBI, Janssen, and BEAM Therapeutics, receives research funding from BEAM Therapeutics and NeoImmune Tech, has patents pending for biomarkers for cytokine release syndrome and CD38 CART for hematologic malignancies. EMB has served on advisory board for SOBI. SWC is a consultant for AB2 Bio, IMMvention Therapeutix, Johnson and Johnson, Novartis, Simcha, and SOBI. AK is a consultant and speaker for SOBI.
